Media coverage
1Media coverage
Title Safety and Efficacy of Talactoferrin in Addition to Standard Chemotherapy in Patients With Non-small Cell Lung Cancer; FORTIS-C Media name/outlet Clinical Trials.gov Country United States Date 10/2/18 Persons Missak Haigentz